Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Immunodiagnostics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
This report reveals a significant growth trajectory in the immunodiagnostics market, projecting an increase from $21.3 billion in 2023 to an expected $30.9 billion by 2028, at a compound annual growth rate (CAGR) of 7.8%.
With a spotlight on the implications of global health trends and technological advancements, the report provides insights into the key drivers propelling the market forward. These include an increasing incidence of infectious diseases, a rise in the prevalence of chronic conditions, such as autoimmune diseases and cancer, as well as the expansion of healthcare infrastructure around the world.
Within the report, immunodiagnostics technologies are identified as pivotal in addressing the needs of various sectors in the medical field, from infectious diseases and oncology to autoimmunity disorders and drug monitoring. The reagents and consumables sector, which includes the vital substances used in diagnostic procedures, remains essential, while instruments and software signify a substantial segment influenced by ongoing technological progress.
Highlighting geographical influences, the report confirms that North America represents the largest share in the global market. However, the Asia-Pacific region is anticipated to witness significant growth, driven by the expansion of healthcare systems and increased healthcare spending.
The document delves into the competitive landscape of the market, featuring major entities that operate within this space. It emphasizes the strategic initiatives, such as acquisitions and partnerships that are shaping the industry. Notably, these collaborations are enhancing diagnostic approaches, with recent examples illustrating integrations of investigational imaging radiotracers with established immuno-diagnostic platforms.
The report uncovers the emergence of point-of-care testing (POCT) and multiplexing technologies as key trends. The evolution of digital immunodiagnostics and the exploration of liquid biopsy are forecasted to have notable impacts on the market dynamics. Companies are also emphasizing the development of ultrasensitive detection technologies to cater to advanced research and health screenings.
Key Market Insights:
- Extensive analysis of market trends, including advancements in personalized medicine and biomarker discovery.
- Detailed segmentation of the immunodiagnostics market, breaking down product types, technologies, applications, and end-users.
- A comprehensive look at the strategies employed by leading companies in the market to sustain growth and competitiveness.
- An in-depth geographic market analysis, highlighting regional market shares, trends, and opportunities.
The immunodiagnostics market report encapsulates a wealth of information and analysis, offering invaluable insights for stakeholders, healthcare providers, policymakers, and market participants looking to understand current market dynamics and future prospects.
A selection of companies mentioned in this report includes
- Abbott Laboratories
- Arkray Inc.
- bioMérieux Inc.
- Immunodiagnostic Systems Holdings Plc (IDS)
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Qiagen N.V.
- Tecan Trading AG
- PerkinElmer Inc.
- Merck KGaA
- Becton Dickinson and Company
- Grifols S.A.
- Ortho Clinical Diagnostics
- Beckman Coulter Inc.
- Bio-Techne Corporation
- Creative Diagnostics
- Fujirebio Holdings Inc.
- Gold Standard Diagnostics Corp.
- Hologic Inc.
- Luminex Corporation
- Myriad Genetics Inc.
- Natera Inc.
- OraSure Technologies Inc.
- Quidel Corporation
For more information about this report visit https://www.researchandmarkets.com/r/nwg81a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
